Table 1.
Distribution of background characteristics among 314 women with ASCUS/LSIL index cytologies.
Fig 1.
Cumulative incidence of CIN2+ by baseline test result.
Log rank p-value: 0.0049 CIN 1+: cervical intraepithelial neoplasia grade 2 or worse, ASCUS: atypical squamous cells of undetermined significance, LSIL: low-grade squamous intraepithelial lesions.
Fig 2.
Cumulative incidence of CIN2+ by baseline age.
Log rank p-value: 0.1499 CIN2+: cervical intraepithelial neoplasia grade 2 or worse
Fig 3.
Cumulative incidence of CIN2+ by baseline HR HPV status.
CIN2+: cervical intraepithelial neoplasia grade 2 or worse, HR HPV: high-risk human papillomavirus. Log rank p-value: <0.0001
Fig 4.
Cumulative incidence of CIN2+ by baseline test result and HR HPV status.
CIN2+: cervical intraepithelial neoplasia grade 2 or worse, ASCUS: atypical squamous cells of undetermined significance, LSIL: low-grade squamous intraepithelial lesions, HR HPV: high-risk human papillomavirus. Log rank p-value: <0.0001
Fig 5.
Cumulative incidence of CIN2+ by baseline test result and HPV status.
CIN2+: cervical intraepithelial neoplasia grade 2 or worse, ASCUS: atypical squamous cells of undetermined significance, LSIL: low-grade squamous intraepithelial lesions, HR HPV: high-risk human papillomavirus. Log rank p-value: <0.0001
Table 2.
Unadjusted association between baseline characteristics and CIN2+.
Table 3.
Adjusted multivariable model*—full study population.